United States News All stories

HSBC Holdings (NYSE:HSBC) reported second-quarter pretax profit of $10.1 billion, up 60%, and launched a $1 billion share buyback.

SRX Global acquired an undisclosed Vistagen Therapeutics (NASDAQ:VTGN) stake on August 4, adding a late clinical-stage neuroscience investment.

L3Harris Technologies (NYSE:LHX) completed the $845 million sale of a majority stake in its commercial space propulsion, power and electronics businesses to AE Industrial Partners.

BP (NYSE:BP) reported a second-quarter 2026 underlying replacement cost profit of $5.7 billion, comfortably beating analyst expectations.

ADTRAN Holdings (NASDAQ:ADTN) reported second-quarter 2026 revenue of $281.1 million, marking a 6.1% year-over-year increase driven by demand in its optical networking business.

IQM Quantum Computers (NASDAQ:IQMX) reported EUR 8.9 million in first-half 2026 revenue alongside a EUR 60.5 million operating loss.

Wix (NASDAQ:WIX) reported a second-quarter 2026 revenue of $563.1 million, representing a 15% year-over-year increase.

Paramount Skydance Corporation (NASDAQ:PSKY) reported second-quarter revenue of $6.913 billion, up 1%, while adjusted EBITDA rose 27% to $1.099 billion.

Prologis (NYSE:PLD) agreed to acquire SEGRO for approximately $18.8 billion to create a global real estate platform.

Dr. Reddy’s (NYSE:RDY) announced the United States launch of Sugammadex Injection, a generic equivalent of Bridion, to expand its hospital portfolio.

Bending Spoons (NASDAQ:BSP) agreed to acquire Airtable in an all-cash transaction reflecting a $1.285 billion enterprise value.

AudioCodes (NASDAQ:AUDC) reported second-quarter 2026 revenues of $63 million, representing a 3.1% year-over-year increase.

Zebra Technologies (NASDAQ:ZBRA) reported second-quarter net sales of $1.557 billion, up 20.4%, while net income reached $233 million.

Palantir Technologies (NASDAQ:PLTR) reported Q2 revenue of $1.94 billion, up 93%, as its U.S. business generated $1.57 billion.

Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q2 revenue of $3.33 billion, up 12%, as its CF and newer treatments generated growth.

Boeing (NYSE:BA) received FAA certification for the 737-7, clearing the smallest 737 MAX variant for commercial service.

Broadcom (NASDAQ:AVGO) lost its court bid to suspend an EU antitrust request for U.S. legal documents related to VMware.

Carrier Global (NYSE:CARR) completed the sale of NORESCO to OPTERRA Energy Services, transferring the business to an LS Power subsidiary.

Alexander’s (NYSE:ALX) reported Q2 net income of $155.4 million, or $30.24 per diluted share, following a major property-sale gain.

Giftify (NASDAQ:GIFT) reported Q2 gross billings of $45.5 million, up 26.2%, while net sales increased 4.0% to $21.7 million.

Douglas Dynamics (NYSE:PLOW) announced its financial results for the second quarter of 2026, reporting record net sales of $214.6 million.

TG Therapeutics (NASDAQ:TGTX) reported Q2 global revenue of $240.3 million as U.S. BRIUMVI sales increased 64% to $227.7 million.

AstraZeneca (NASDAQ:AZN) has reportedly engaged in early-stage negotiations regarding a potential merger with Bristol Myers Squibb (NYSE:BMY).

Sportradar (NASDAQ:SRAD) reported Q2 revenue of €378 million, up 19%, while adjusted EBITDA increased 19% to €76 million.